#170: SCAI releases new consensus on "ad hoc" PCI; societies prepare interventionalists for new payment codes; heart-healthy diet additive to drug benefits in secondary prevention; increased mortality with digoxin in AF; warfarin for six months should be
SCAI releases new consensus on "ad hoc" PCI; societies prepare interventionalists for new payment codes; heart-healthy diet additive to drug benefits in secondary prevention; increased mortality with digoxin in AF; warfarin for six months should be (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - December 14, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#169: Pall cast on Durata ICD lead as FDA document made public; "holistic" analysis shows domino effect of TAVI risk factors; CT coronary angiography identifies significant plaques in "normal" arteries; major bleeds with warfarin in AF are often fatal;
Pall cast on Durata ICD lead as FDA document made public; "holistic" analysis shows domino effect of TAVI risk factors; CT coronary angiography identifies significant plaques in "normal" arteries; major bleeds with warfarin in AF are often fatal; low seru (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 30, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#19: The hormonal dilemma: Unraveling an "acute confusional state"
Where do things stand with hormone-replacement therapy? Dr Sharon Mulvagh joins Dr Bernard Gersh to shine light on the notoriously complicated data—including the HERS, WHI, KEEPS, and DOPS trials—and show why the trial results are not as contradictory as (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 28, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
#168: Diabetes risk outweighed by CV benefit of statins; "threshold" effect for vitamin D and CVD: New meta-analysis; European approvals for apixaban in AF, rivaroxaban for PE/DVT; New guidelines emphasize OMT for stable IHD; FDA approves HeartWare VAD
Diabetes risk outweighed by CV benefit of statins; "threshold" effect for vitamin D and CVD: New meta-analysis; European approvals for apixaban in AF, rivaroxaban for PE/DVT; New guidelines emphasize OMT for stable IHD; FDA approves HeartWare VAD fo (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 23, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#53: Beta blockers in stable heart disease with Dr Sripal Bangalore
Despite cautious and limited guideline endorsement, beta blockers are widely used in cardiovascular disease (and beyond). Why? Our guest Dr Sripal Bangalore discusses his research, which caused a stir in CV spheres but actually does not differ greatly fro (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 20, 2012 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#167: Dabigatran looks good long term: RELY-ABLE; occasional cocaine use can do acute and chronic damage; MADIT-RIT: Simple programming change averts most inappropriate ICD therapy; BLOCK-HF: Replace
Dabigatran looks good long term: RELY-ABLE; occasional cocaine use can do acute and chronic damage; MADIT-RIT: Simple programming change averts most inappropriate ICD therapy; lipid profiles: Fasting not necessary, concludes study; BLOCK-HF: Replace RV p (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 16, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#18: Radiofrequency ablation in AF
Despite years of research, our understanding of this field remains limited. Dr Douglas Packer joins the show to discuss the pathophysiology of atrial fibrillation in regard to the targets for radiofrequency ablation, how the procedure has changed in the p (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 13, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
#166: CABG superior to PCI in diabetics in FREEDOM; impressive antihypertensive effect of flaxseed; what role for PFO closure?; TACT: Surprising, puzzling benefit from chelation therapy after MI; TRILOGY/ARCTIC: Back to the drawing board for platelet moni
CABG superior to PCI in diabetics in FREEDOM; impressive antihypertensive effect of flaxseed; what role for PFO closure?; TACT: Surprising, puzzling benefit from chelation therapy after MI; TRILOGY/ARCTIC: Back to the drawing board for platelet monitoring (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 9, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#165: What's hot at AHA 2012; PFO-closure trials RESPECT and PC miss primary end point; prasugrel bests clopidogrel in TRILOGY-ACS angiography cohort; RIVAL: Major benefits with radial PCI in STEMI vs NSTEMI; RF ablation, antiarrhythmic meds comparable as
What's hot at AHA 2012; PFO-closure trials RESPECT and PC miss primary end point; prasugrel bests clopidogrel in TRILOGY-ACS angiography cohort; RIVAL: Major benefits with radial PCI in STEMI vs NSTEMI; RF ablation, antiarrhythmic meds comparable as (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 2, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#12: Are patients best served by reporting, transparency, and appropriate-use criteria?
Recent ruminations on public reporting (of PCI) generally conclude with the notion that patient outcomes are better in states that report. Right? Not according to Dr Paul Teirstein, who offers his cath-lab experience in California and New York to present (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 30, 2012 Category: Cardiology Authors: theheart.org Tags: Topol and Teirstein: The Click and Rub Show Source Type: podcasts
#164: In diabetics, lifestyle management fails to reduce hard CV outcomes: Look AHEAD halted; rivaroxaban okayed for PE in Europe; PFO closure trials take spotlight at TCT 2012; small increased risk of CV events with diclofenac; FDA expands Sapien TAVI in
In diabetics, lifestyle management fails to reduce hard CV outcomes: Look AHEAD halted; rivaroxaban okayed for PE in Europe; PFO closure trials take spotlight at TCT 2012; small increased risk of CV events with diclofenac; FDA expands Sapien TAVI in (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 26, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#17: Treating ventricular tachycardia in patients without structural heart disease
Dr Bernard Gersh asks Dr Samuel Asirvatham about the syndromes that categorize patients who have ventricular tachycardia in the absence of structural heart disease and what the treatment options—including ablation—are for these patients. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 24, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
#163: HRT cuts CVD by 50%, latest "unique" data show; WSJ: St Jude knew of Riata lead flaws at end of 2005; MIST investigator accused of false data; pacemaker implants with CoreValve edge lower; NHANES: Lipid levels improve across US over 20 years
HRT cuts CVD by 50%, latest "unique" data show; WSJ: St Jude knew of Riata lead flaws at end of 2005; MIST investigator accused of false data; pacemaker implants with CoreValve edge lower; NHANES: Lipid levels improve across US over 20 years (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 19, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#52: Patient adherence and drug discontinuation with Dr Niteesh Choudhry
A combination of many issues—such as misunderstanding the importance of medications, forgetfulness, finances, and more complex social factors—patient nonadherence to drug therapy is a major public concern and an impediment to global health. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 17, 2012 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#2: Policies to address cardiovascular disease in India with Dr Srinath Reddy
Now that the risk to health from noncommunicable diseases is being taken very seriously, what action is the government taking to contain cardiovascular disease in India? (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 15, 2012 Category: Cardiology Authors: theheart.org Tags: Cardiology in India with Dr Denis Xavier Source Type: podcasts
